| Status | Study |
| Recruiting |
Study Name: A Study to Evaluate the Safety and Pharmacokinetics of RadProtect® in Healthy Volunteers Condition: Acute Radiation Syndrome Date: 2015-10-26 Interventions: Drug: RadProtect® This study will evaluate RadProtect® at sequential, escalating dose levels. |
| Completed |
Study Name: Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome Condition: Acute Radiation Syndrome Date: 2015-01-13 Interventions: Biological: HemaMax Recombinan |
| Completed |
Study Name: Safety and Tolerability of HemaMax™ (rHuIL-12) as Radiation Countermeasure Condition: Hematopoietic Syndrome Due to Acute Radiation Syndrome Date: 2012-08-06 Interventions: Biological: HemaMax Placebo Other Name: rHuIL-12 |
| Completed |
Study Name: Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation Condition: Thrombocytopenia Acute Radiation Syndrome Date: 2009-05-15 Interventions: Drug: Eltrombopag dose escalation |
| Completed |
Study Name: Safety and Pharmacokinetic Study of BIO 300 Capsules Condition: Acute Radiation Syndrome Date: 2007-07-19 Interventions: Drug: BIO 300 Capsules |